Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. Co.'s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). Co. also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. We show 33 historical shares outstanding datapoints in our CODX shares outstanding history coverage, used to compute CODX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CODX market cap history over the course of time is important for investors
interested in comparing CODX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CODX versus a peer is one thing; comparing
CODX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CODX can fluctuate over the course of history.
With this page we aim to empower investors researching CODX by allowing them to research the CODX market cap history. |
Free CODX Email Alerts:
Video: The Importance of Market Cap
